Skip to main content
. 2012 Mar 1;74(5):815–823. doi: 10.1111/j.1365-2125.2012.04260.x

Figure 2.

Figure 2

Pharmacokinetic/pharmacodynamic (PK/PD) model of metformin. The PK are described by a one compartment model in which concentration in the central compartment (Cp) is linked to the PD model. The drug (D) interacts with the receptor (R) and produces a drug−receptor complex (DR) that initiates a series of signal transduction processes. τ is the mean production time for second messengers (M1–M3)